Ligand Pharmaceuticals Inc (LGND)
P/OCF Ratio
46.91×
TTM · Retrieved:

LGND P/OCF Ratio
Current (TTM)46.91×retrieved
Current (TTM)46.91×retrieved
LGND Quarterly P/OCF Ratio (-40.83× → 264.04×)
Latest values, visible window
High-resolution chart · PNG
LGND p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| 264.04× | |
| 81.5272× | |
| 81.354× | |
| 262.0833× | |
| 139.0829× | |
| -79.0775× | |
| 71.4082× | |
| 50.467× | |
| 114.8923× | |
| 69.8237× | |
| 175.2982× | |
| 136.2032× | |
| -15,190.239× | |
| 36.9728× | |
| 21.0999× | |
| 44.2786× | |
| 79.043× | |
| 22.6979× | |
| 58.3312× | |
| 72.4272× | |
| 66.9074× | |
| 145.3383× | |
| 1,857.3875× | |
| 74.4347× | |
| 45.9486× | |
| 44.3066× | |
| -150.917× | |
| -188.0938× | |
| -22.8653× | |
| 34.9503× | |
| 54.7605× | |
| 132.5635× | |
| 37.2256× | |
| 35.9633× | |
| 56.9004× | |
| 64.7219× | |
| 153.2173× | |
| 57.0777× | |
| 63.1045× | |
| 71.7959× | |
| 147.5422× | |
| 105.4981× | |
| 98.6653× | |
| 101.8073× | |
| 123.5832× | |
| 124.4672× | |
| 64.3913× | |
| 160.2216× | |
| 201.0704× | |
| 335.5105× | |
| 55.7356× | |
| -1,531.0698× | |
| 72.688× | |
| 160.3103× | |
| 119.3587× | |
| -227.4703× | |
| -285.1772× | |
| -531.4507× | |
| 20.7285× | |
| -159.0636× | |
| -18.1969× | |
| 134.4117× | |
| -83.8842× | |
| -15.1175× | |
| -48.292× | |
| -8.0273× | |
| -118.8258× | |
| -14.3654× | |
| 68.4002× | |
| -8.7149× | |
| 26.3708× | |
| -13.0076× | |
| -38.8187× | |
| -25.2308× | |
| -32.7289× | |
| -23.1105× | |
| -14.5996× | |
| -13.9617× | |
| -6.5513× | |
| -17.5846× | |
| -64.2216× | |
| -31.0883× | |
| 42.6447× | |
| 68.92× | |
| -40.6009× | |
| -101.7528× | |
| 19.0847× | |
| -65.615× | |
| -68.7194× | |
| -254.1628× | |
| 70.5878× | |
| -216.0378× | |
| 169.9472× | |
| -29.173× | |
| -24.2155× | |
| -85.8416× | |
| -48.9054× | |
| -5,582.5829× | |
| -191.1407× | |
| -49.7937× |